We are live on ! Find out more
SPC

Slate Path Capital Portfolio holdings

AUM $6.73B
1-Year Est. Return 95.97%
This Fund
S&P 500
This Quarter Est. Return
-21.63%
1 Year Est. Return
+95.97%
3 Year Est. Return
+272.8%
5 Year Est. Return
+330.15%
10 Year Est. Return
+4,591.92%
AUM
$1.3B
AUM Growth
-$553M
Cap. Flow
-$90.5M
Cap. Flow %
-6.94%
Top 10 Hldgs %
85.39%
Holding
34
New
7
Increased
6
Reduced
9
Closed
8

Top Buys

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$207M
2
PAAS icon
Pan American Silver
PAAS
+$17.2M
3
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$15.7M
4
ENDP
Endo International plc
ENDP
+$15.3M
5
MOS icon
The Mosaic Company
MOS
+$7.21M

Top Sells

Rank Stock Value
1
SNAP icon
Snap
SNAP
+$75.5M
2
MDCO
Medicines Co
MDCO
+$69.5M
3
EQT icon
EQT Corp
EQT
+$54.2M
4
SBSW icon
Sibanye-Stillwater
SBSW
+$39.1M
5
Z icon
Zillow
Z
+$35.8M

Sector Composition

Rank Sector Weight
1 Communication Services 37.94%
2 Materials 28.45%
3 Healthcare 27.34%
4 Industrials 4.32%
5 Consumer Discretionary 0.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARCH
26
DELISTED
Arch Resources, Inc.
ARCH
$520K 0.04%
+18,000
New +$922K
AG icon
27
First Majestic Silver
AG
$7.41B
– –
-170,000
Closed -$2.08M
EQT icon
28
EQT Corp
EQT
$33.3B
– –
-4,970,000
Closed -$54.2M
SBSW icon
29
Sibanye-Stillwater
SBSW
$6.26B
– –
-3,935,000
Closed -$39.1M
SNAP icon
30
CALL
Snap
SNAP
$7.89B
– –
-110,000
Closed -$1.8M
TDW icon
31
Tidewater
TDW
$3.73B
– –
-110,000
Closed -$2.12M
X
32
DELISTED
US Steel
X
– –
-40,000
Closed -$456K
RETA
33
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-120,000
Closed -$24.5M
MDCO
34
DELISTED
Medicines Co
MDCO
– –
-818,042
Closed -$69.5M
1
2

Similar funds

SPS
Susquehanna Portfolio Strategies Bala Cynwyd, Pennsylvania $6.73B AUM 45.57% 1-Year Est. Return
BHM
Briar Hall Management Nashville, Tennessee $6.72B AUM 4.95% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
CIMLRA
CBRE Investment Management Listed Real Assets Radnor, Pennsylvania $6.75B AUM 8.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return
MSE
MUFG Securities EMEA London, United Kingdom $6.7B AUM 32.3% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Slate Path Capital's Q1 2020 Portfolio in Review

As of Q1 2020, Slate Path Capital held 34 positions worth $1.3B, down 30% from $1.86B the previous quarter. Its ten largest holdings account for 85% of the portfolio.

Slate Path Capital withdrew a net $90.5M in Q1 2020, closing 8 positions and reducing 9 holdings. Its most notable exit was Medicines Co, an estimated $69.5M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 38% of assets, down from 39% a quarter earlier, followed by Materials and Healthcare.

Against the trend, Slate Path Capital opened a new position in Viatris worth $161M.

  • Slate Path Capital's largest Q1 2020 buy was Viatris: 10,785,000 shares worth $161M.
  • Slate Path Capital added most to Pan American Silver in Q1 2020, an estimated $17.2M increase.
  • Slate Path Capital's biggest Q1 2020 reduction was Snap, cutting an estimated $75.5M.
  • Slate Path Capital fully exited Medicines Co in Q1 2020, selling an estimated $69.5M.
  • Slate Path Capital's ten largest holdings make up 85% of its $1.3B portfolio in Q1 2020.
  • Slate Path Capital opened 7 new positions and closed 8 in Q1 2020.
  • Slate Path Capital's portfolio value fell 30% quarter-over-quarter to $1.3B.

Based on Slate Path Capital's 13F filing for Q1 2020, filed 15 May 2020.